BOSTON SCIENTIFIC CORP is 33.2x more valuable than LEMAITRE VASCULAR INC by market capitalization ($70.11 B vs $2.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LMAT | BSX |
|---|---|---|
| Market cap | $2.11 B | $70.11 B |
| US-listed rank | #2074 | #243 |
| Revenue (latest FY) | $249.60M | $20.07B |
| Net income (latest FY) | $57.70M | - |
| Net margin | 23.1% | - |
| P/E (trailing FY) | 36.6 | - |
| SEC filings | 1,849 | 1,009 |
BOSTON SCIENTIFIC CORP is 33.2x more valuable than LEMAITRE VASCULAR INC by market capitalization ($70.11 B vs $2.11 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: LEMAITRE VASCULAR INC and BOSTON SCIENTIFIC CORP, or browse the full rankings.